Free Trial
NASDAQ:LUCY

Innovative Eyewear (LUCY) Stock Price, News & Analysis

Innovative Eyewear logo
$2.87 +0.04 (+1.41%)
Closing price 03:58 PM Eastern
Extended Trading
$2.89 +0.02 (+0.70%)
As of 05:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Innovative Eyewear Stock (NASDAQ:LUCY)

Key Stats

Today's Range
$2.77
$3.00
50-Day Range
$2.83
$6.08
52-Week Range
$2.55
$27.20
Volume
11,380 shs
Average Volume
956,635 shs
Market Capitalization
$7.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.

Remove Ads

Innovative Eyewear Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
19th Percentile Overall Score

LUCY MarketRank™: 

Innovative Eyewear scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Innovative Eyewear.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Innovative Eyewear is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Innovative Eyewear is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Innovative Eyewear has a P/B Ratio of 0.33. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.32% of the float of Innovative Eyewear has been sold short.
  • Short Interest Ratio / Days to Cover

    Innovative Eyewear has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Innovative Eyewear has recently decreased by 1.26%, indicating that investor sentiment is improving.
  • Dividend Yield

    Innovative Eyewear does not currently pay a dividend.

  • Dividend Growth

    Innovative Eyewear does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.32% of the float of Innovative Eyewear has been sold short.
  • Short Interest Ratio / Days to Cover

    Innovative Eyewear has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Innovative Eyewear has recently decreased by 1.26%, indicating that investor sentiment is improving.
  • News Sentiment

    Innovative Eyewear has a news sentiment score of 1.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Innovative Eyewear this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Innovative Eyewear insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.42% of the stock of Innovative Eyewear is held by insiders.

  • Percentage Held by Institutions

    Only 0.96% of the stock of Innovative Eyewear is held by institutions.

  • Read more about Innovative Eyewear's insider trading history.
Receive LUCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innovative Eyewear and its competitors with MarketBeat's FREE daily newsletter.

LUCY Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

LUCY Stock Analysis - Frequently Asked Questions

Innovative Eyewear's stock was trading at $4.92 at the beginning of the year. Since then, LUCY stock has decreased by 41.7% and is now trading at $2.87.
View the best growth stocks for 2025 here
.

Innovative Eyewear, Inc. (NASDAQ:LUCY) issued its quarterly earnings data on Monday, March, 24th. The company reported ($0.41) earnings per share for the quarter, topping analysts' consensus estimates of ($1.16) by $0.75. The company earned $1 million during the quarter, compared to analysts' expectations of $1 million. Innovative Eyewear had a negative trailing twelve-month return on equity of 115.86% and a negative net margin of 514.01%.

Innovative Eyewear's stock reverse split on Thursday, July 18th 2024. The 1-20 reverse split was announced on Thursday, July 18th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 18th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Innovative Eyewear (LUCY) raised $8 million in an initial public offering (IPO) on the week of August 15th 2022. The company issued 900,000 shares at a price of $7.50-$9.50 per share. Maxim Group acted as the underwriter for the IPO.

Shares of LUCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Innovative Eyewear investors own include Sangamo Therapeutics (SGMO), Meta Platforms (META), NVIDIA (NVDA), Faraday Future Intelligent Electric (FFIE), Mullen Automotive (MULN), NIO (NIO) and Verizon Communications (VZ).

Company Calendar

Last Earnings
3/24/2025
Today
3/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Ophthalmic goods
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:LUCY
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-6,660,000.00
Net Margins
-514.01%
Pretax Margin
-513.95%

Debt

Sales & Book Value

Annual Sales
$1.64 million
Price / Cash Flow
N/A
Book Value
$8.61 per share
Price / Book
0.33

Miscellaneous

Free Float
2,285,000
Market Cap
$6.94 million
Optionable
Not Optionable
Beta
2.75
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:LUCY) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners